Cronos Group Stock News

TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Third Quarter Earnings Conference Call on Friday, February 18, 2022 at 8:30 a.m. EST. Cronos Group’s senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Third Quarter Earnings Conference Call on Friday, F

Cronos Group Inc. (NASDAQ:CRON) (TSX:

On November 9, 2021, the company announced that it applied for a management cease trade order with the applicable securities regulatory authorities in Canada on the basis that the company would be una

TORONTO, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is providing a default status report in accordance with the alternat

Companies are struggling amid sluggish market conditions, but analysts expect narrower losses even as revenue falls.

WASHINGTON, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Cannabidiol (CBD) Market finds that increasing awareness of cannabidiol''s therapeutic benefits is expediting market growth. Primarily driven by increasing demand for cannabidiol (CBD) for health and wellness purposes is high, the total Global Cannabidiol (CBD) Market is estimated to reach USD 47.22 Billion by 2028, up from USD 4.9 Billion in 2021, at a compound annual growth rate (CAGR) of 21.3%. Furthermore, rising acceptance and use of CBD products due to government approvals to augment the growth of the Global Cannabidiol (CBD) Market, states Vantage Market Research, in a report, titled " Cannabidiol (CBD) Market by Source (Hemp, Marijuana), by Distribution Channel (Online, Offline), by End-Use (Medical, Personal Use, Pharmaceuticals, Wellness), by Region (North America, Latin America, Europe, Asia Pacific) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)". Click Here To Access The Free Sample Report @ https://www.vantagemarketresearch.com/cannabidiol-cbd-market-1252/request-sample (The Free Sample Of This Report Is Readily Available On Request).

Columbia Care Inc. and Trulieve Cannabis Corp. announced separate debt deals in recent days as cannabis companies turn away from issuing stock to raise capital in the face of weak share prices.

Cannara’s Valleyfield Facility This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. In the fall of 2018, Canada became the second country in the world to legalize the recreational use of marijuana . Since that time the Canadian cannabis industry has grown dramatically. Last year saw revenues top $3 billion, and that number is expected to double by 2026, according to Statista.com. These massive revenues have been driven by first movers in the Canadian market like Tilray Inc. (NASDAQ: TLRY ), Canopy Growth Corp. (NASDAQ: CGC ), and Cronos Group Inc. (NASDAQ: CRON ). These producers represent what … Full story available on Benzinga.com

Cannabis industry expert Alan Brochstein on 2022 catalysts.

These companies wouldn't be worth a second look, even in a less volatile market.

These companies wouldn't be worth a second look, even in a less volatile market.

Jefferies upgraded two Canadian cannabis stocks on Thursday and reduced his price target on a third, remaining most bullish on buy-rated OrganiGram Holdings Inc., which it said is “really starting t

While the U.S. pot growers had an amazing 2021, dark clouds loomed over their Canadian counterparts.

Fire & Flower Holdings Corp. said it has filed to list its stock on the Nasdaq as the latest Canadian pot company to trade on a major U.S. exchange after Tilray , Canopy Growth , Aurora Cannabis , Cronos Group , OrganiGram Holdings and others. "Listing on the Nasdaq will allow us to expand our shareholder base and drive increased shareholder value as we continue to leverage our unique technology-driven business model to enter new targeted markets across North America," Fire & Flower CEO Trevor Fencott said in a statement on Wednesday. The company said it would announce when its stock will officially start trading on the Nasdaq and did not yet disclose its Nasdaq ticker symbol. OTC-listed shares of Fire & Flower are up 4% so far in 2022 and down 44% in the past 12 months, compared to a loss of nearly 8% in 2022 and a drop of 56% in the past 12 months by the Cannabis ETF . Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.